Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 6/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | CPA1 | P15085 | 2/20 | 0.43 |
| ▸ | CPB1 | P15086 | 1/20 | 0.43 |
| ▸ | CPA3 | P15088 | 1/20 | 0.43 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
| ▸ | MME | P08473 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21802279 | 0.86 | FOLH1 (0.75) | FOLH1TDP1CPA1CPB1CPA3 | |
| SCHEMBL164322 | 0.86 | FOLH1 (0.75) | FOLH1TDP1CPA1CPB1CPA3 | |
| SCHEMBL28035405 | 0.85 | FOLH1 (0.60) | FOLH1TDP1CPA1CPB1CPA3 | |
| SCHEMBL7240454 | 0.83 | FOLH1 (0.58) | FOLH1TDP1CPA1CPB1CPA3 | |
| SCHEMBL3893901 | 0.83 | CHRM1 (0.55) | FOLH1TDP1CPB2CHRM1AKR1A1 | |
| SCHEMBL9728224 | 0.81 | FOLH1 (0.45) | FOLH1TDP1CHRM1AKR1A1CHRM3 | |
| SCHEMBL29217 | 0.81 | FOLH1 (0.68) | FOLH1TDP1CPA1CPB1CPA3 | |
| Ammonia Solution, Strong SCHEMBL8998230 | 0.80 | TDP1 (0.52) | FOLH1TDP1CPB2CHRM1AKR1A1 | |
| SCHEMBL11363310 | 0.80 | FOLH1 (0.43) | FOLH1TDP1CPB2CHRM1AKR1A1 | |
| SCHEMBL27959736 | 0.80 | FOLH1 (0.43) | FOLH1TDP1CPA1CPB1CPA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9643857-B2 | Methods of preparing high purity aluminum hydroxide and high purity aluminum oxide | Shanghai Phichem Material Co., Ltd. (CN) | 2017-05-09 | — | — | US | claimed |
| US-20160115041-A1 | METHODS OF PREPARING HIGH PURITY ALUMINUM HYDROXIDE AND HIGH PURITY ALUMINUM OXIDE | Shanghai Phichem Material Co., Ltd. (CN) | 2016-04-28 | — | — | US | claimed |
| US-12622982-B2 | Implants and biodegradable tissue markers | INCEPT, LLC (US) | 2026-05-12 | — | — | US | disclosed |
| US-12544735-B1 | Calcium metaborate/lead tetroxide/magnesium borate/carbon nanocomposite and method of preparation | IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) | 2026-02-10 | — | — | US | disclosed |
| US-20250161497-A1 | IMPLANTS AND BIODEGRADABLE TISSUE MARKERS | INCEPT, LLC | 2025-05-22 | — | — | US | disclosed |
| EP-2396070-B1 | DRUG DELIVERY THROUGH HYDROGEL PLUGS | INCEPT LLC (US) | 2024-12-04 | — | — | EP | disclosed |
| EP-3960215-B1 | IMPLANTS AND BIODEGRADABLE FIDUCIAL MARKERS | INCEPT LLC (US) | 2024-10-16 | — | — | EP | disclosed |
| WO-2023238909-A1 | ELECTROLYTE SOLUTION AND SECONDARY BATTERY USING SAME | ダイキン工業株式会社 | 2023-12-14 | — | — | WO | disclosed |
| US-11786612-B2 | Implant and biodegradable tissue marker compositions and methods | INCEPT, LLC (US) | 2023-10-17 | — | — | US | disclosed |
| US-11572564-B2 | Microorganisms for producing 1,4-butanediol and methods related thereto | GENOMATICA, INC. (US) | 2023-02-07 | — | — | US | disclosed |
| US-11324828-B2 | Hydrogel polymeric compositions and methods | INCEPT, LLC (US) | 2022-05-10 | — | — | US | disclosed |
| EP-1102782-B1 | STRUCTURAL ANALOGS OF AMINE BASES AND NUCLEOSIDES | BIO RAD LABORATORIES (US) | 2006-03-29 | — | — | EP | disclosed |
| CN-1231815-C | Ultraviolet-curing resin composition and photo solder resist ink containing the same | GOO CHEMICAL CO LTD (JP) | 2005-12-14 | — | — | CN | disclosed |
| CN-1210620-C | Ultraviolet-curable resin composition and photosolder resist ink containing same | GOO CHEMICAL CO LTD (JP) | 2005-07-13 | — | — | CN | disclosed |
| CN-1459049-A | Ultraviolet-curable resin composition and photosolder resist ink contaning the composition | GOO CHEMICAL CO LTD (JP) | 2003-11-26 | — | — | CN | disclosed |
| CN-1455889-A | Ultraviolet curable resin composition and photosolder resist ink comprising the same | GOO CHEMICAL CO LTD (JP) | 2003-11-12 | — | — | CN | disclosed |
| CN-1115585-C | Shading spacer for liquid crystal and liquid crystal display element | NATOCO PAINT KK (JP) | 2003-07-23 | — | — | CN | disclosed |
| US-6335432-B1 | FOR FLUORESCENT HYBRIDIZATION PROBES FOR USE IN DIAGNOSIS, RESEARCH, AND THERAPY | BIO-RED LABORATORIES, INC. | 2002-01-01 | — | — | US | disclosed |
| CN-1205450-A | Shading spacer for liquid crystal and liquid crystal display element | NATOCO PAINT KK (JP) | 1999-01-20 | — | — | CN | disclosed |
| US-4311618-A | Cleanser with ionic and nonionic surfactants | SCHAEFER BURKHARD WERNER | 1982-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11324828-B2 | Hydrogel polymeric compositions and methods | CRYAA, CRYAB, UACA | FOLH1 872/4885TDP1 445/4885CPA1 1264/4885 |
| US-12622982-B2 | Implants and biodegradable tissue markers | CD44, MUC1, FUCA1 | FOLH1 1219/4885TDP1 2888/4885CPA1 2433/4885 |
| US-12544735-B1 | Calcium metaborate/lead tetroxide/magnesium borate/carbon nanocomposite and method of preparation | CA2, CACNA2D4, KCNN4 | FOLH1 3606/4885TDP1 3713/4885CPA1 4607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.